Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Nicole R. LeBoeuf et al.|New England Journal of Medicine|2016Cited by 595
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S. Davids, Philippe Armand, Haesook T. Kim et al.|Blood|2020Cited by 98
A Multicenter Phase I Study of CTLA-4 Blockade with Ipilimumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|Blood|2014Cited by 17
A Phase I/Ib Study of Nivolumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (alloHCT)Matthew S. Davids, Philippe Armand, Haesook T. Kim et al.|Blood|2018Cited by 13
A Multicenter Phase I/Ib Study of Ipilimumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Stem Cell TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|Blood|2015Cited by 11